The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

Each Unit Includes One Class A Ordinary Share andOne Share Right to Receive 1/10th of a Class A Ordinary ShareNew York, NY, March 03, 2025 ...

We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...

MNTN, Inc. (“MNTN”), a technology platform that brings performance marketing to Connected TV, announced that it filed a ...

While Kallyope’s drugs are mechanistically unique, the biotech is competing in a crowded space, with other therapies that ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...

On February 3, three insiders purchased a total of around $94.22 million worth of Metsera shares during the company’s initial ...

LG Electronics Inc. has started roadshows to meet potential investors in the initial public offering of its Indian unit, people familiar with the matter said. Voler Car’s IPO allotment will be ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. RedCloud - London ...